Girls’ Generation K-pop group member Im Yoon-ah (or Lim Yoon-a) has been offered a part in the new drama A Tyrant’s Chef. Described as a time travel drama, the show is the latest from director ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

The latest award from the Administration for Strategic Preparedness and Response of $72 million includes $37.9 million for CSL, $23.4 million for Sanofi, and $10.5 million for GSK. Read Next: ...

Also Read: FDA Approves Regeneron/Sanofi’s Blockbuster Dupixent For Smoker’s Lung Disease. The FDA approved the drug in 2022. Administered as chronic IV treatment. Enjaymo generated ...

Now it’s trading hands again, through a deal announced Friday. Sanofi is selling global rights to Enjaymo to the Italy-based drugmaker Recordati, in exchange for an upfront payment of $825 million.

CAD is a rare blood disorder where B cells produce antibodies that destroy red blood cells. Credit: Siwakorn TH via Shutterstock. Recordati has reached an agreement with Sanofi for acquiring the ...

Sept 27 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a chronic ...

Clayton Dubilier & Rice made it a condition for banks to commit more than €1 billion ($1.1 billion) of debt to fund a part of the equity check for its bid for Sanofi’s consumer-health division ...

Regeneron REGN1.05%increase; green up pointing triangle Pharmaceuticals and Sanofi SAN-0.46%decrease; red down pointing triangle have won U.S. Food and Drug Administration expanded approval of ...

There are 300,000 such people in the U.S., according to Regeneron and Sanofi, which jointly developed Dupixent.

Tom Kim and Sungjae Im's decision to leave the eighth green at Royal Montral and head to the ninth tee while Scottie Scheffler still had a birdie putt during their fourball match caused quite the ...